Need help?

Biopharmaceuticals Company Investment Opportunity in Hyderabad, India

US FDA & Brazilian ANVISA approved CRO offering clinical research services to global pharma industry.
This Business is on a Premium Plan
Established 5-10 year(s)
Employees 100 - 500
Legal Entity Private Limited Company
Reported Sales USD 3 - 4 million
Run Rate Sales USD 3.14 million
EBITDA Margin 20 - 30 %
Industries Biopharmaceuticals
Locations  Hyderabad
Local Time 10:26 AM Asia / Kolkata
Listed By Management Member
Status Active
Overall Rating
Partial Stake Sale
USD 1.74 million for 10.0% stake (Native Currency: INR 150,000,000)
Reason: Funds are required for working capital & payable. Based on our valuation we expect this.
Includes physical assets worth USD 6.4 million
Interested to connect with advisors
Documents
Business Overview
- Revenue projections of INR 100 crores (USD 13 million) in 5 years.
- US FDA & ANVISA approved CRO.
- Facility equipped with 100 beds and 4 LCMS / MS.
- Offering Clinical research solutions. Some of the services we would offer are clinical research, diagnostic, bio analytics, pharmacokinetics.
- Promoters have over 18 years of expertise in the same business.
Products & Services Overview
Clinical research, bioequivalence & bioavailability studies, patient pk studies, bioanalytics, pharmacokinetics and biostatistics.
Assets Overview
- Physical assets worth approx. INR 55 crore (USD 7 million)
- 100,000 sq. ft. built-up area (G+1) which includes clinics, labs, office areas, and parking areas.
- Medical equipment, bio-analytical equipment, furniture, and fixtures.
Facilities Overview
- 2 acres of land.
- 100,000 sq. ft. built-up area (G+1) which includes clinics, labs, office areas, and parking areas.
Capitalization Overview
Not Disclosed
Recent Activity
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
35 Investors already contacted this Business. Register below to connect now!
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses
    Frequently
    Asked
    Questions
    • Why can’t I see the business’ name or contact number? How do I contact the business?
    • What level of due diligence does SMERGERS conduct on the businesses/member?
    • How active are the business profiles listed on SMERGERS?
    • How does SMERGERS rate business profiles?
    • Do I need to pay to connect with a business?
    • Show more